Cormorant Asset Management LP 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:05 pm Sale |
2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
Cormorant Asset Management LP | 1,679,442 2.020% |
-4,731,913 (-73.81%) |
Filing |
| 2021-02-16 3:33 pm Sale |
2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
Cormorant Asset Management LP | 6,411,355 7.760% |
-475,000 (-6.90%) |
Filing |
| 2020-11-13 4:01 pm Purchase |
2020-11-03 | 13G | Atea Pharmaceuticals, Inc. AVIR |
Cormorant Asset Management LP | 6,886,355 8.340% |
6,886,355 (New Position) |
Filing |